Today: 11 April 2026
BitMine Immersion (BMNR) stock in focus after report flags persistent Korea retail buying despite 80% slide
1 January 2026
2 mins read

BitMine Immersion (BMNR) stock in focus after report flags persistent Korea retail buying despite 80% slide

NEW YORK, January 1, 2026, 06:34 ET — Market closed

  • BitMine Immersion Technologies shares last closed at $27.15, down about 2% in the final session of 2025.
  • A CoinDesk report said South Korean retail investors were net buyers of about $1.4 billion of BMNR in 2025 despite the stock’s steep pullback from July highs.
  • Investors are watching crypto prices during the U.S. market holiday ahead of Friday’s reopening and BitMine’s Jan. 15 shareholder vote.

BitMine Immersion Technologies (BMNR) shares slipped in the final session of 2025 as U.S. markets shut for New Year’s Day, with traders weighing a fresh report on persistent buying by South Korean retail investors.

The move matters because BitMine has increasingly traded as a high-volatility proxy for ether, the cryptocurrency that powers the Ethereum network, rather than a straight bitcoin miner. Crypto trades around the clock, so token swings over the holiday can feed into the stock when U.S. equities reopen.

It also highlights how cross-border retail flows can keep momentum names active even after sharp drawdowns, especially when the underlying narrative is tied to crypto balance-sheet strategies and thin year-end liquidity.

BMNR last closed at $27.15 on Wednesday, down $0.55, or about 2%, after trading between $26.86 and $28.22. Volume was about 33.9 million shares, and bitcoin was down about 1% while ether was little changed in late U.S. trading.

CoinDesk said South Korean retail investors were net buyers of about $1.4 billion of BitMine stock in 2025, ranking it second among overseas equities behind Alphabet, citing Korea Securities Depository data referenced by Bloomberg. The report also pointed to demand for leveraged products such as T-Rex’s 2X Long BitMine Daily Target ETF, which targets roughly twice the stock’s daily move and resets each day.

The stock’s boom-and-bust profile has been extreme. CoinDesk said shares were down about 82% from a July 3 peak, after a rally of more than 3,000% tied to BitMine’s pivot toward building an “ether treasury” — a strategy that prioritizes holding tokens on the balance sheet. Coindesk

BitMine said late last month that it held 4.11 million ether tokens and $1.0 billion in cash as of Dec. 28, valuing its crypto and cash holdings at $13.2 billion at then-prevailing prices. “Bitmine added 44,463 ETH in the past week,” chairman Thomas “Tom” Lee said in the release. PR Newswire

The company has also been urging shareholders to vote ahead of its annual meeting on Jan. 15, where proposals include increasing authorized common shares and approving a 2025 omnibus incentive plan, according to its proxy materials.

Crypto-linked stocks often move with underlying tokens and broader risk appetite. U.S. equities eased into the year-end close in light holiday trading, with the S&P 500 falling 0.7% on Wednesday.

Before the next session on Friday, investors will watch whether crypto holds its holiday range and how much risk appetite returns after thin year-end liquidity.

For BitMine, the near-term calendar is dominated by the Jan. 15 vote, which investors see as a read-through on shareholder support for the company’s capital flexibility and compensation framework. Approval of additional share capacity can ease future fundraising but can also raise dilution concerns.

Stock Market Today

  • Merck Shares Show Bullish Pattern With Potential Breakout Ahead
    April 11, 2026, 5:45 PM EDT. Merck's stock is forming an inverse head-and-shoulders pattern, a reliable technical setup signaling a possible bullish breakout above $124. The breakout could push prices toward $135, offering notable upside. This comes amid broader strength in the drug sector, where Merck has consistently converted consolidation phases into gains. Importantly, Merck's quarterly chart reveals historical trends of multi-year rebounds after major pullbacks, suggesting possible long-term gains beyond $134. The stock's interaction with rising weekly moving averages will be critical going forward, as these lines have historically served as support during rallies and resistance when momentum fades. Merck's next earnings report on April 30 could catalyse this setup. Traders and investors should watch for further consolidation to define this pattern before a potential breakout attempt.

Latest article

India F-35 Deal Hits Pause: Lockheed Martin Says No Direct Talks, U.S. Door Still Open

India F-35 Deal Hits Pause: Lockheed Martin Says No Direct Talks, U.S. Door Still Open

11 April 2026
Lockheed Martin said it is not in direct talks with India over the F-35, clarifying that any approach must go through official U.S. and Indian channels under the Foreign Military Sales process. Indian officials confirmed no formal discussions on acquiring the F-35 have begun. India recently approved a $40 billion military upgrade, including other fighter jets, while Lockheed’s F-21 remains in a separate competition.
Why SNOW Stock Is Falling Again: Snowflake Nears 52-Week Low as AI Worries Hit Software

Why SNOW Stock Is Falling Again: Snowflake Nears 52-Week Low as AI Worries Hit Software

11 April 2026
Snowflake shares fell 8.4% to $121.11 on Friday after an 11.7% drop Thursday, as investors sold off software stocks amid concerns over new AI tools from Anthropic and OpenAI. The stock now trades just above its 52-week low. The S&P 500 Software and Services Index is down 25.5% for the year. Snowflake reported fourth-quarter product revenue of $1.23 billion, up 30% from a year earlier.
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 11.04.2026

11 April 2026
LIVEMarkets rolling coverageStarted: April 11, 2026, 12:00 AM EDTUpdated: April 11, 2026, 5:47 PM EDT Merck Shares Show Bullish Pattern With Potential Breakout Ahead April 11, 2026, 5:45 PM EDT. Merck's stock is forming an inverse head-and-shoulders pattern, a reliable technical setup signaling a possible bullish breakout above $124. The breakout could push prices toward $135, offering notable upside. This comes amid broader strength in the drug sector, where Merck has consistently converted consolidation phases into gains. Importantly, Merck's quarterly chart reveals historical trends of multi-year rebounds after major pullbacks, suggesting possible long-term gains beyond $134. The stock's interaction with
Nike stock jumps 4% after CEO Elliott Hill buys $1 million in shares as markets shut for New Year’s Day
Previous Story

Nike stock jumps 4% after CEO Elliott Hill buys $1 million in shares as markets shut for New Year’s Day

Applied Digital (APLD) stock in spotlight as analysts tout upside ahead of Jan. 7 earnings
Next Story

Applied Digital (APLD) stock in spotlight as analysts tout upside ahead of Jan. 7 earnings

Go toTop